Article
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.
International journal of molecular sciences - 8 Sept 2022
Fiorino Erika, Merlini Alessandra, D'Ambrosio Lorenzo, Cerviere Ilaria, Berrino Enrico, Marchiò Caterina, Giraudo Lidia, Basiricò Marco, Massa Annamaria, Donini Chiara, Leuci Valeria, Rotolo Ramona, Galvagno Federica, Vitali Letizia, Proment Alessia, Ferrone Soldano, Pisacane Alberto, Pignochino Ymera, Aglietta Massimo, Grignani Giovanni, Mesiano Giulia, Sangiolo Dario
Abstract excerpt
Gastrointestinal stromal tumors (GISTs) are rare, mesenchymal tumors of the gastrointestinal tract, characterized by either KIT or PDGFRA mutation in about 85% of cases. KIT/PDGFRA wild type gastrointestinal stromal tumors (wtGIST) account for the remaining 15% of GIST and represent an unmet medical need: their prevalence and potential medical vulnerabilities are not completely defined, and effective therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
